LOSMP will attend ACI’s Life Sciences IP Due Diligence Summit in Boston, Dec 3–4, 2025, focused on best practices for safeguarding and valuing IP portfolios.
LOSMP to Attend ACI’s Pharma & Biotech Patent Litigation Forum 2025
In a May 2025 decision, the U.S. Supreme Court allows presidential replacement of independent agency leaders before their constitutional challenges are resolved.
The Federal Circuit revived UC Berkeley’s claim to key CRISPR gene editing patents, directing the USPTO to reconsider if its findings predate Broad Institute’s.
